论文信息 - Secukinumab dosing optimization in patients with moderate‐to‐severe plaque psoriasis: results from the randomized, open‐label OPTIMISE study - 字舞流文

Secukinumab dosing optimization in patients with moderate‐to‐severe plaque psoriasis: results from the randomized, open‐label OPTIMISE study

K. Reich | J. Szepietowski | J. Szepietowski | C. Paul | L. Puig | J. Lacour | A. Tsianakas | C. Sieder | R. Orsenigo | M. Rissler | E. Pournara | L. Puig | Carle Paul